Health care startups that raised Series C in Boston, Massachusetts
Updated 16 Nov 2026
Not sure about the data?
Download a free 10-row sample first. No account, no payment.
| Company | City | Last round | Amount | Date |
|---|---|---|---|---|
| Delix Therapeutics | Boston | Series C | $100.0M | 2026-11-09 |
| Ratio Therapeutics | Boston | Series C | $70.0M | 2026-07-31 |
| InStride Health | Boston | Series C | $30.0M | 2026-06-15 |
| Cerevance | Boston | Series C | $20.0M | 2026-05-12 |
| AcuityMD | Boston | Series C | $80.0M | 2026-04-21 |
| Cohere Health | Boston | Series C | $90.0M | 2025-05-14 |
| Elektrofi | Boston | Series C | $112.2M | 2024-08-22 |
| Scorpion Therapeutics | Boston | Series C | $150.0M | 2024-07-16 |
8 rows of the CSV in 5 of its 18 columns.
- The 29 health care startups in Boston, Massachusetts whose last round is Series C have raised $3.9B in total.
- 5 of them closed their most recent round in the last 12 months, $300.0M combined.
- The largest of those rounds is Delix Therapeutics' $100.0M Series C, dated November 2026.
- F-Prime is an investor in 3 of them, more than any other fund.
- Software is the most common other sector, with 14 companies (48%).
- 10% were founded in 2020 or later; the median founding year is 2016.
- The most common team size is 101 to 250 employees (38% of companies with a recorded size).
Source: FundingWatcher. Data as of 16 November 2026. "Last 12 months" is the 365 days to that date.
Newest rounds
6 of 29| Company | What they do | Sector | Last round | Amount | Date | Total raised | Investors | Employees | Founded |
|---|---|---|---|---|---|---|---|---|---|
| Delix Therapeutics | Delix Therapeutics develops psychoplastogen therapies that promote neuroplasticity. | Biotech | Series C | $100.0M | 2026-11-09 | $244.1M | Gaingels, RA Capital Management, Dolby Family Ventures +2 | 11 to 50 | 2019 |
| Ratio Therapeutics | Ratio Therapeutics develops radiopharmaceuticals to treat solid tumors in clinical trials. | Biotech | Series C | $70.0M | 2026-07-31 | $160.0M | Bristol-Myers Squibb, The Pags Group, Schusterman Family Investments | 11 to 50 | 2021 |
| InStride Health | InStride Health provides evidence-based OCD and anxiety treatment to children and teenagers. | Health care | Series C | $30.0M | 2026-06-15 | $86.0M | General Catalyst, .406 Ventures, Mass General Brigham Ventures +2 | 251 to 500 | 2021 |
| Cerevance | Cerevance develops novel therapeutics for neurological diseases. | Biotech | Series C | $20.0M | 2026-05-12 | $209.5M | Google Ventures, Casdin Capital, Foresite Capital +1 | 51 to 100 | 2016 |
| AcuityMD | AcuityMD provides AI-powered data analysis to help companies make informed commercial decisions in healthcare. | Artificial intelligence | Series C | $80.0M | 2026-04-21 | $163.0M | Redpoint, Benchmark, ICONIQ Growth +2 | 251 to 500 | 2019 |
| Overjet | Overjet is a software company that offers an AI platform for dentistry and educates patients. | Artificial intelligence | Series C | $53.2M | 2024-03-05 | Insight Partners, General Catalyst, Liquid 2 Ventures +2 | 101 to 250 | 2018 |
Table 1. Health care startups that raised Series C in Boston, Massachusetts: the 6 newest rounds whose row carries a description, a city, a named fund and an amount. Source: FundingWatcher. Data as of 16 November 2026. Base: 29.
Largest rounds
Last 12 months| # | Company | What they do | Sector | Last round | Amount | Date | Total raised | Investors | Employees | Founded |
|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Delix Therapeutics | Delix Therapeutics develops psychoplastogen therapies that promote neuroplasticity. | Biotech | Series C | $100.0M | 2026-11-09 | $244.1M | Gaingels, RA Capital Management, Dolby Family Ventures +2 | 11 to 50 | 2019 |
| 2 | AcuityMD | AcuityMD provides AI-powered data analysis to help companies make informed commercial decisions in healthcare. | Artificial intelligence | Series C | $80.0M | 2026-04-21 | $163.0M | Redpoint, Benchmark, ICONIQ Growth +2 | 251 to 500 | 2019 |
| 3 | Ratio Therapeutics | Ratio Therapeutics develops radiopharmaceuticals to treat solid tumors in clinical trials. | Biotech | Series C | $70.0M | 2026-07-31 | $160.0M | Bristol-Myers Squibb, The Pags Group, Schusterman Family Investments | 11 to 50 | 2021 |
| 4 | InStride Health | InStride Health provides evidence-based OCD and anxiety treatment to children and teenagers. | Health care | Series C | $30.0M | 2026-06-15 | $86.0M | General Catalyst, .406 Ventures, Mass General Brigham Ventures +2 | 251 to 500 | 2021 |
| 5 | Cerevance | Cerevance develops novel therapeutics for neurological diseases. | Biotech | Series C | $20.0M | 2026-05-12 | $209.5M | Google Ventures, Casdin Capital, Foresite Capital +1 | 51 to 100 | 2016 |
Table 2. Health care startups that raised Series C in Boston, Massachusetts: the 5 largest rounds of the last 12 months. Source: FundingWatcher. Data as of 16 November 2026.
Most active investors
By companies backed| # | Investor | Type | Location | Companies | Share | Funded, 12 months | Latest |
|---|---|---|---|---|---|---|---|
| 1 | F-Prime | Venture capital firm | Cambridge, United States | 3 | 10% | ||
| 2 | .406 Ventures | Venture capital firm | Boston, United States | 2 | 7% | 1 | InStride Health |
| 3 | General Catalyst | Venture capital firm | San Francisco, United States | 2 | 7% | 1 | InStride Health |
| 4 | Google Ventures | Corporate venture arm | San Francisco, United States | 2 | 7% | 1 | Cerevance |
| 5 | Polaris Partners | Private equity firm | Boston, United States | 2 | 7% | ||
| 6 | The Blue Venture Fund | Private equity firm | Chicago, United States | 2 | 7% | ||
| 7 | Eight Roads Ventures | Venture capital firm | London, United Kingdom | 2 | 7% | ||
| 8 | Gaingels | Syndicate | Burlington, United States | 1 | 3% | 1 | Delix Therapeutics |
| 9 | Casa Verde Capital | Venture capital firm | Los Angeles, United States | 1 | 3% | 1 | Delix Therapeutics |
| 10 | Artis Ventures | Venture capital firm | San Francisco, United States | 1 | 3% | 1 | Delix Therapeutics |
| 11 | Dolby Family Ventures | Venture capital firm | San Francisco, United States | 1 | 3% | 1 | Delix Therapeutics |
| 12 | RA Capital Management | Startup incubator | Boston, United States | 1 | 3% | 1 | Delix Therapeutics |
| 13 | Bristol-Myers Squibb | Venture capital firm | New York, United States | 1 | 3% | 1 | Ratio Therapeutics |
| 14 | The Pags Group | Family office | Boston, United States | 1 | 3% | 1 | Ratio Therapeutics |
| 15 | Schusterman Family Investments | Family office | New York, United States | 1 | 3% | 1 | Ratio Therapeutics |
Table 3. Health care startups that raised Series C in Boston, Massachusetts: the funds recorded as investors in the most companies. Latest: companies they back that raised in the last 12 months. Source: FundingWatcher. Data as of 16 November 2026.
Sectors
| Sectors | Companies | Share | Total raised |
|---|---|---|---|
| Software | 14 | 48% | $1.3B |
| Biotech | 13 | 45% | $2.9B |
| Artificial intelligence | 5 | 17% | $681.2M |
| Hardware | 1 | 3% | $41.7M |
| Commerce | 1 | 3% | $56.9M |
| Education | 1 | 3% | $12.0M |
Table 4. Health care startups that raised Series C in Boston, Massachusetts by sector. Source: FundingWatcher. Data as of 16 November 2026.
Funding stage
| Funding stage | Companies | Share | Median last round |
|---|---|---|---|
| Series C | 29 | 100% | $43.0M |
Table 5. Health care startups that raised Series C in Boston, Massachusetts by stage of the most recent round. Source: FundingWatcher. Data as of 16 November 2026.
Rounds by month
| Rounds by month | Companies | Share | Raised |
|---|---|---|---|
| November 2026 | 1 | 20% | $100.0M |
| July 2026 | 1 | 20% | $70.0M |
| June 2026 | 1 | 20% | $30.0M |
| May 2026 | 1 | 20% | $20.0M |
| April 2026 | 1 | 20% | $80.0M |
Table 6. Health care startups that raised Series C in Boston, Massachusetts: most recent round by month, last 12 months. Source: FundingWatcher. Data as of 16 November 2026.
Most recent round by year
| Most recent round by year | Companies | Share | Raised |
|---|---|---|---|
| 2026 | 5 | 17% | $300.0M |
| 2025 | 3 | 10% | $162.0M |
| 2024 | 3 | 10% | $315.4M |
| 2023 | 1 | 3% | $40.0M |
| 2022 | 4 | 14% | $207.9M |
| 2021 | 3 | 10% | $147.0M |
Table 7. Health care startups that raised Series C in Boston, Massachusetts by year of the most recent round. Source: FundingWatcher. Data as of 16 November 2026.
Founding year
| Founding year | Companies | Share |
|---|---|---|
| 2020 to 2022 | 3 | 10% |
| 2015 to 2019 | 15 | 52% |
| 2010 to 2014 | 7 | 24% |
| Before 2010 | 4 | 14% |
Table 8. Health care startups that raised Series C in Boston, Massachusetts by founding year. Source: FundingWatcher. Data as of 16 November 2026.
Team size
| Team size | Companies | Share |
|---|---|---|
| 11 to 50 | 8 | 28% |
| 51 to 100 | 6 | 21% |
| 101 to 250 | 11 | 38% |
| 251 to 500 | 3 | 10% |
| 501 to 1,000 | 1 | 3% |
Table 9. Health care startups that raised Series C in Boston, Massachusetts by headcount. Source: FundingWatcher. Data as of 16 November 2026.
Method
- A company is on this list when Health care is one of its sectors and its most recent funding round is Series C and its headquarters is in Boston, Massachusetts. On 16 November 2026 that is 29 companies.
- Stage, round, amount and date are those of the company's most recent funding round. Amounts are in US dollars as the source records them.
- The table prints the 6 newest rounds whose row is complete: a one-sentence description, a city, a named fund and an amount. The CSV carries all 29 rows: 1 have no round amount, 0 no city and 2 no website. The CSV carries domain, website, LinkedIn and the cached description sentence where present.
Sources, fields and exclusions of both files: Method.
Questions
- How many health care startups in Boston, Massachusetts whose last round is Series C are on the list?
- 29, in the file dated 16 November 2026. 5 of them closed their most recent round in the last 12 months.
- What does the CSV contain?
- One row per company, 18 columns: name, domain, website, linkedin, description, founded, employees, city, region, country, sectors, funding_stage, last_round, last_round_date, last_round_usd, total_raised_usd, rounds, investors.
- How much does the list cost?
- $29 one-time for all 29 rows, no account. Every investor and every startup, two files, cost $99. With founder contacts, up to 2 founders or CEOs per company compiled to order and mailed within 24 hours, $199.
- What arrives after payment?
- At once: the CSV download link, on the page after payment and by mail.
- Can I see rows before buying?
- The 3 rows under the buy button are rows of the CSV with every column. The form below it mails 10 rows.
- How current is the data?
- The file is dated 16 November 2026. The download link serves the current file each time it is opened.
Not sure about the data?
Download a free 10-row sample first. No account, no payment.